Operating Margin of Revolution Medicines, Inc. from 31 Dec 2018 to 30 Sep 2024
- Taxonomy & unit
- ratio: %
- Description
- The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
- Summary
-
Revolution Medicines, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2018 to 30 Sep 2024.
- Revolution Medicines, Inc. Operating Margin for the quarter ending 30 Sep 2024 was -88032%, a 6144% decline year-over-year.
- Revolution Medicines, Inc. annual Operating Margin for 2023 was -4207%, a 476% decline from 2022.
- Revolution Medicines, Inc. annual Operating Margin for 2022 was -730%, a 14% decline from 2021.
- Revolution Medicines, Inc. annual Operating Margin for 2021 was -640%, a 148% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
Revolution Medicines, Inc. Quarterly Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q3 2024 | -88032% | -86622% | -6144% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -80961% | -79870% | -7319% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -12109% | -11318% | -1430% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -4207% | -3477% | -476% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -1410% | -564% | -67% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -1091% | -262% | -32% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -791% | -14% | -1.8% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -730% | -90% | -14% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -845% | -256% | -43% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -830% | -473% | -133% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -777% | -472% | -154% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -640% | -382% | -148% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -590% | -382% | -184% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | -357% | -179% | -100% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | -306% | -172% | -128% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | -258% | -149% | -138% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | -208% | 01 Jul 2020 | 30 Sep 2020 | ||
| Q2 2020 | -178% | 01 Apr 2020 | 30 Jun 2020 | ||
| Q1 2020 | -134% | 01 Jan 2020 | 31 Mar 2020 | ||
| Q4 2019 | -108% | 01 Oct 2019 | 31 Dec 2019 |
Revolution Medicines, Inc. Annual Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2023 | -4207% | -3477% | -476% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -730% | -90% | -14% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -640% | -382% | -148% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | -258% | -149% | -138% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -108% | +92% | +46% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | -200% | 01 Jan 2018 | 31 Dec 2018 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.